Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P (2010) Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 17(3–4):101–104. https://doi.org/10.3109/13506129.2010.526812

Article  CAS  PubMed  Google Scholar 

Zhang KW, Stockerl-Goldstein KE, Lenihan DJ (2019) Emerging therapeutics for the treatment of light chain and transthyretin amyloidosis. JACC Basic Transl Sci 4(3):438–448. https://doi.org/10.1016/j.jacbts.2019.02.002

Article  PubMed  PubMed Central  Google Scholar 

Klaassen SHC, Tromp J, Nienhuis HLA, van der Meer P, van den Berg MP, Blokzijl H et al (2018) Frequency of and prognostic significance of cardiac involvement at presentation in hereditary transthyretin-derived amyloidosis and the value of N-terminal pro-B-type natriuretic peptide. Am J Cardiol 121(1):107–112. https://doi.org/10.1016/j.amjcard.2017.09.029

Article  CAS  PubMed  Google Scholar 

Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M et al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379(11):1007–1016. https://doi.org/10.1056/NEJMoa1805689

Article  CAS  PubMed  Google Scholar 

Adams D, Gonzalez-Duarte A, O’Riordan WD, Yang CC, Ueda M, Kristen AV et al (2018) Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 379(1):11–21. https://doi.org/10.1056/NEJMoa1716153

Article  CAS  PubMed  Google Scholar 

Mohammed SF, Mirzoyev SA, Edwards WD, Dogan A, Grogan DR, Dunlay SM et al (2014) Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart failure 2(2):113–122. https://doi.org/10.1016/j.jchf.2013.11.004

Article  PubMed  PubMed Central  Google Scholar 

Tanskanen M, Peuralinna T, Polvikoski T, Notkola IL, Sulkava R, Hardy J et al (2008) Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med 40(3):232–239. https://doi.org/10.1080/07853890701842988

Article  CAS  PubMed  Google Scholar 

Castano A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A et al (2017) Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 38(38):2879–2887. https://doi.org/10.1093/eurheartj/ehx350

Article  PubMed  PubMed Central  Google Scholar 

Gonzalez-Lopez E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C et al (2015) Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 36(38):2585–2594. https://doi.org/10.1093/eurheartj/ehv338

Article  CAS  PubMed  Google Scholar 

Oghina S, Bougouin W, Bezard M, Kharoubi M, Komajda M, Cohen-Solal A et al (2021) The impact of patients with cardiac amyloidosis in HFpEF trials. JACC Heart failure 9(3):169–178. https://doi.org/10.1016/j.jchf.2020.12.005

Article  PubMed  Google Scholar 

Oerlemans M, Rutten KHG, Minnema MC, Raymakers RAP, Asselbergs FW, de Jonge N (2019) Cardiac amyloidosis: the need for early diagnosis. Netherlands Heart J 27(11):525–536. https://doi.org/10.1007/s12471-019-1299-1

Article  CAS  Google Scholar 

Conceicao I, Damy T, Romero M, Galan L, Attarian S, Luigetti M et al (2019) Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid 26(1):3–9. https://doi.org/10.1080/13506129.2018.1556156

Article  CAS  PubMed  Google Scholar 

Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404–2412. https://doi.org/10.1161/CIRCULATIONAHA.116.021612

Article  CAS  PubMed  Google Scholar 

Glaudemans AW, van Rheenen RW, van den Berg MP, Noordzij W, Koole M, Blokzijl H et al (2014) Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis. Amyloid 21(1):35–44. https://doi.org/10.3109/13506129.2013.871250

Article  CAS  PubMed  Google Scholar 

Ross JC, Hutt DF, Burniston M, Grigore SF, Fontana M, Page J et al (2021) The role of serial (99m)Tc-DPD scintigraphy in monitoring cardiac transthyretin amyloidosis. Amyloid 29(1):38–49. https://doi.org/10.1080/13506129.2021.1991302

Article  CAS  PubMed  Google Scholar 

Rapezzi C, Guidalotti P, Salvi F, Riva L, Perugini E (2008) Usefulness of 99mTc-DPD scintigraphy in cardiac amyloidosis. J Am Coll Cardiol 51(15):1509–10; author reply 10. https://doi.org/10.1016/j.jacc.2007.12.038

Article  PubMed  Google Scholar 

Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L et al (2005) Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 46(6):1076–1084. https://doi.org/10.1016/j.jacc.2005.05.073

Article  PubMed  Google Scholar 

Van den Wyngaert T, Strobel K, Kampen WU, Kuwert T, van der Bruggen W, Mohan HK et al (2016) The EANM practice guidelines for bone scintigraphy. Eur J Nucl Med Mol Imaging 43(9):1723–1738. https://doi.org/10.1007/s00259-016-3415-4

Article  PubMed  PubMed Central  Google Scholar 

Cuscaden C, Ramsay SC, Prasad S, Goodwin B, Smith J (2020) Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation. J Nucl Cardiol. https://doi.org/10.1007/s12350-020-02152-x

Article  PubMed  Google Scholar 

Bianco M, Parente A, Biolè C, Righetti C, Spirito A, Luciano A et al (2021) The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy. J Nucl Cardiol 28(3):825–830. https://doi.org/10.1007/s12350-021-02575-0

Article  PubMed  Google Scholar 

Mohamed-Salem L, Santos-Mateo JJ, Sanchez-Serna J, Hernandez-Vicente A, Reyes-Marle R, Castellon Sanchez MI et al (2018) Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population. Int J Cardiol 270:192–196. https://doi.org/10.1016/j.ijcard.2018.06.006

Article  PubMed  Google Scholar 

Suomalainen O, Pilv J, Loimaala A, Matzke S, Helio T, Uusitalo V (2020) Prognostic significance of incidental suspected transthyretin amyloidosis on routine bone scintigraphy. J Nucl Cardiol. https://doi.org/10.1007/s12350-020-02396-7

Article  PubMed  PubMed Central  Google Scholar 

Longhi S, Guidalotti PL, Quarta CC, Gagliardi C, Milandri A, Lorenzini M et al (2014) Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy. JACC Cardiovasc Imaging 7(5):531–532. https://doi.org/10.1016/j.jcmg.2014.03.004

Article  PubMed  Google Scholar 

Treglia G, Martinello C, Dondi F, Albano D, Bertagna F, Rizzo A et al (2023) Prevalence of incidental findings suspicious for transthyretin cardiac amyloidosis among patients undergoing bone scintigraphy: a systematic review and a meta-analysis. J Clin Med 12(17):5698. https://doi.org/10.3390/jcm12175698

Article  PubMed  PubMed Central  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. https://doi.org/10.1093/eurheartj/ehab368

Article  PubMed  PubMed Central  Google Scholar 

Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA (2010) Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 56(2):254–261. https://doi.org/10.1373/clinchem.2009.132654

Article  CAS  PubMed  Google Scholar 

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1-39.e14. https://doi.org/10.1016/j.echo.2014.10.003

Article  PubMed  Google Scholar 

Nagueh SF, Smiseth OA, Appleton CP, Byrd BF III, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17(12):1321–1360. https://doi.org/10.1093/ehjci/jew082

Article  PubMed  Google Scholar 

Rapezzi C, Lorenzini M, Longhi S, Milandri A, Gagliardi C, Bartolomei I et al (2015) Cardiac amyloidosis: the great pretender. Heart Fail Rev 20(2):117–124. https://doi.org/10.1007/s10741-015-9480-0

Article  CAS  PubMed  Google Scholar 

Lousada I, Maurer MS, Warner MT, Guthrie S, Hsu K, Grogan M (2019) Amyloidosis Research Consortium Cardiac Amyloidosis Survey: results from patients with AL and ATTR amyloidosis and their caregivers. J Cardiac Fail 25(8):S69. https://doi.org/10.1016/j.cardfail.2019.07.197

Article  Google Scholar 

Gnanasegaran G, Cook G, Adamson K, Fogelman I (2009) Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CT. Semin Nucl Med 39(6):380–395. https://doi.org/10.1053/j.semnuclmed.2009.07.003

Article  PubMed  Google Scholar 

Delbarre M-A, Girardon F, Roquette L, Blanc-Durand P, Hubaut M-A, Hachulla É et al (2023) Deep learning on bone scintigraphy to detect abnormal cardiac uptake at risk of cardiac amyloidosis. JACC Cardiovasc Imaging. https://doi.org/10.1016/j.jcmg.2023.01.014

Article  PubMed  Google Scholar 

Scully PR, Morris E, Patel KP, Treibel TA, Burniston M, Klotz E et al (2020) DPD quantification in cardiac amyloidosis: a novel imaging biomarker. JACC Cardiovasc Imaging 13(6):1353–1363. https://doi.org/10.1016/j.jcmg.2020.03.020